Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 34,711 | 40,588 | 38,213 | 37,200 | 38,903 |
| Cost of Goods | 10,638 | 11,119 | 11,914 | 9,857 | 8,457 |
| Gross Profit | 24,073 | 29,469 | 26,299 | 27,343 | 30,446 |
| Operating Expenses | 29,476 | 29,550 | 31,306 | 29,837 | 27,749 |
| Operating Income | -4,765 | 38 | -4,093 | -1,637 | 3,154 |
| Other Income | -3,346 | -2,992 | -13,402 | -744 | -519 |
| Pre-tax Income | -8,111 | -2,954 | -17,495 | -2,381 | 2,635 |
| Net Income Continuous | -8,111 | -2,954 | -17,495 | -2,381 | 2,635 |
| Net Income | $-8,111 | $-2,954 | $-17,495 | $-2,381 | $2,635 |
| EPS Basic Total Ops | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 |
| EPS Basic Continuous Ops | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 |
| EPS Diluted Total Ops | -0.04 | -0.01 | -0.10 | -0.02 | 0.01 |
| EPS Diluted Continuous Ops | -0.04 | -0.02 | -0.10 | -0.02 | 0.01 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.02 | -0.05 | -0.02 | 0.01 |
| EBITDA(a) | $-4,160 | $690 | $-3,932 | $-539 | $3,635 |